Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Alexander

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Deutsche Medizinische Wochenschrift (1946)|January 23, 2015
[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome]Marc Nguyen-Tat, Esther Götz, Peter Scholz-Kreisel, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Trials|August 7, 2014
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trialRoman Kloeckner, Christian Ruckes, Kai Kronfeld, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Deutsche Medizinische Wochenschrift (1946)|January 23, 2015
[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome]Marc Nguyen-Tat, Esther Götz, Peter Scholz-Kreisel, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Trials|August 7, 2014
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trialRoman Kloeckner, Christian Ruckes, Kai Kronfeld, et al.
Pageof 14